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Abstract
Background: Strawberry flavonoids are potent antioxidants and anti-inflammatory agents that
have been shown to reduce cardiovascular disease risk factors in prospective cohort studies.
Effects of strawberry supplementation on metabolic risk factors have not been studied in obese
populations. We tested the hypothesis that freeze-dried strawberry powder (FSP) will lower fasting
lipids and biomarkers of oxidative stress and inflammation at four weeks compared to baseline. We
also tested the tolerability and safety of FSP in subjects with metabolic syndrome. FSP is a
concentrated source of polyphenolic flavonoids, fiber and phytosterols.
Methods: Females (n = 16) with 3 features of metabolic syndrome (waist circumference >35
inches, triglycerides > 150 mg/dL, fasting glucose > 100 mg/dL and < 126 mg/dL, HDL <50 mg/dL,
or blood pressure >130/85 mm Hg) were enrolled in the study. Subjects consumed two cups of
the strawberry drink daily for four weeks. Each cup had 25 g FSP blended in water. Fasting blood
draws, anthropometrics, dietary analyses, and blood pressure measurements were done at baseline
and 4 weeks. Biomarkers of oxidative stress and inflammation were measured using ELISA
techniques. Plasma ellagic acid was measured using HPLC-UV techniques.
Results: Total cholesterol and LDL-cholesterol levels were significantly lower at 4 weeks versus
baseline (-5% and -6%, respectively, p < 0.05), as was lipid peroxidation in the form of
malondialdehyde and hydroxynonenal (-14%, p < 0.01). Oxidized-LDL showed a decreasing trend
at 4 weeks (p = 0.123). No effects were noted on markers of inflammation including C-reactive
protein and adiponectin. A significant number of subjects (13/16) showed an increase in plasma
ellagic acid at four weeks versus baseline, while no significant differences were noted in dietary
intakes at four weeks versus baseline. Thus, short-term supplementation of freeze-dried
strawberries appeared to exert hypocholesterolemic effects and decrease lipid peroxidation in
women with metabolic syndrome.
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Background
Colorful fruits and vegetables containing a wide range of
phytochemicals have been associated with significant car-
diovascular health benefits. Strawberries are an especially
good source of phytochemicals, particularly anthocyanins
and ellagic acid, which have potent antioxidant and anti-
inflammatory functions [1]. Apples and strawberries have
also been reported to be the largest contributors of cellular
antioxidant activity among all fruits consumed in the
United States [2]. Strawberry juice extracts have been
shown to significantly inhibit free radicals [3], and reduce
ox-LDL-induced proliferation of rat aortic smooth muscle
cells [4]. Ellagic acid supplementation also reduced oxida-
tive stress and atherosclerotic lesion formation in hyperli-
pidemic rabbits [5]. da Silva et al., using in vitro models,
reported the anti-hyperglycemic effects of Brazilian straw-
berries [6]. In animal models, freeze-dried strawberry
powder was shown to reduce obesity and improve glyc-
emic control in mice fed a high-fat diet [7], while mice fed
anthocyanin extracts from strawberries demonstrated an
up regulation of anti-inflammatory adiponectin gene. [8].
Although there are limited findings related to strawberry
supplementation, the data suggest the possibility of straw-
berries in reducing cardiovascular disease risk factors.
Epidemiological observations also suggest that strawber-
ries may have beneficial cardiovascular effects in women.
The Iowa Women's Health Study, a prospective study con-
ducted among 34,489 overweight postmenopausal
women, found a significant inverse association between
strawberry intake and cardiovascular disease mortality
after 16 years of follow-up [9]. The Women's Health
study, a cross-sectional study among 26,966 overweight
postmenopausal women, further reported that women
with higher intakes of strawberries (≥ 2 servings/week)
had a borderline significant reduced risk of elevated C-
reactive protein (CRP), versus those who consumed none
[10]. Thus, these observations suggest the need for addi-
tional human studies to determine possible antioxidant,
anti-inflammatory, and vascular protective effects of
strawberries.
Metabolic syndrome, a significant health problem in the
developed countries, is a constellation of risk factors,
including atherogenic dyslipidemia (low HDL, high trig-
lyceride), impaired fasting glucose, hypertension, and
central adiposity, predisposing to higher risks of oxidative
stress, type 2 diabetes and atherosclerotic cardiovascular
disease [11-14]. Dietary modifications are one of the key
elements in the management of these metabolic abnor-
malities. Intervention studies using strawberries in
humans are limited and have mainly been conducted to
investigate the bioavailability and metabolism of straw-
berry anthocyanins [15,16]. On the basis of this back-
ground information, we tested the effects of a freeze-dried
strawberry drink on selected cardiovascular risk factors,
such as fasting glucose, lipids, and biomarkers of lipid
peroxidation and inflammation, as well as safety and tol-
erability in subjects with metabolic syndrome. Variables
of interests were measured at baseline and at the end of
the study (4 weeks).
Methods
Objectives
To test the hypothesis that freeze-dried strawberry powder
supplementation will decrease serum lipids, glucose, oxi-
dative stress and inflammation, we conducted a feeding
study among 16 women with metabolic syndrome, con-
suming 50 g freeze-dried strawberry powder daily for four
weeks. In this uncontrolled study, effects on body weight,
blood pressure, fasting glucose, lipids, dietary intakes,
plasma ellagic acid, biomarkers of oxidative stress and
inflammation, safety parameters and tolerance were
investigated at baseline and at 4 weeks of the study.
Study design and subjects
Women (n = 16) ranging in age from 39 to 71 years (mean
51 ± 9.1 years) were recruited at Oklahoma State Univer-
sity (OSU) Stillwater campus during June to October,
2008. All subjects had an elevated BMI (> 30), waist cir-
cumference (> 35 inches), elevated systolic blood pressure
(> 130 mm Hg), and low HDL(< 50 mg/dL), fulfilling the
criteria of metabolic syndrome as defined by the National
Cholesterol Education Program, Adult Treatment Panel III
[17]. In addition, all subjects recruited had dyslipidemia
in the form of elevated triglycerides (> 150 mg/dL) or cho-
lesterol (>200 mg/dL) or low HDL (<50 mg/dL). Subjects
were excluded if they were on medications for any chronic
disease (cancer, cardiovascular disease, diabetes mellitus),
pregnant or lactating, used any form of tobacco products,
consumed alcohol (>1 oz/day), used mega doses of anti-
oxidants or fish oil supplements (> 1 g/day), or had any
abnormalities in hematology, liver, renal, and thyroid
function tests which were confirmed with screening labo-
ratory reports. Subjects were recruited through flyers and
e-mail advertisements and were scheduled for a screening
blood draw following an initial telephone screen. The 4-
week study was conducted according to the guidelines laid
down in the Declaration of Helsinki and all procedures
involving human subjects were approved by the Institu-
tional Review Board at Oklahoma State University. Writ-
ten informed consent was obtained from each subject.
Subjects who qualified were asked to refrain from other
sources of berries, green tea, cocoa, and soy products
while on the study. These were the commonly consumed
flavonoid-rich foods by the enrolled subjects as identified
by a screening food frequency questionnaire specific for
flavonoids. Subjects were asked to consume 2 cups of
strawberry drink per day; each cup had 25 g of freeze-driedNutrition Journal 2009, 8:43 http://www.nutritionj.com/content/8/1/43
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strawberry powder, one cup of water, one teaspoon of arti-
ficial sweetener Splenda®, and one teaspoon vanilla
essence. The freeze-dried strawberry powder was donated
by the California Strawberry Commission (Watsonville,
CA, USA). All participants made 3 day (Monday, Wednes-
day, and Friday) per week visits to drink the first cup in the
morning under observation by the research staff and were
provided with the remaining supply of the strawberry
drink in containers. Subjects were asked to drink the sec-
ond cup at least six hours later in the day, and were
instructed to keep the drink under refrigeration, avoid
exposing the drink to direct heat or light or avoid consum-
ing the strawberry drink with any other snack, lunch or
dinner. Subjects were asked to bring back any uncon-
sumed or left-over drink to assess unmonitored compli-
ance. The nutritional value of the freeze-dried strawberry
powder has been illustrated in Table 1. The freeze-dried
strawberry powder was approximately 10% of the fresh
weight of strawberries and had no added ingredients in
the powder.
Body weight, height, blood pressure, waist circumference
measurements and fasting blood draws by a certified phle-
botomist were conducted on the screening visit (baseline)
and at final visit at the end of four weeks of the study.
Systolic and diastolic blood pressure was measured in mm
Hg using Spot Vital Signs Device (Welch Allyn, Ska-
neateles Falls, NY). Participants were asked to lie down
and relax for approximately 8-10 minutes, following
which three blood pressure measurements were recorded
at an interval of 5 minutes at screen and 4 weeks of the
study. Subjects were asked to maintain their usual diet,
physical activity and lifestyle while enrolled in the study.
Subjects were compensated on a weekly basis.
Blood collection and analyses
Fasting blood samples (45 mL) were collected in SST
tubes and in tubes containing EDTA as the anticoagulant
at screen (baseline) and four weeks of the study following
a 12-hour fast by the subjects. Serum and plasma were
separated by centrifugation at 3000 rpm for 10 minutes at
4°C using Centrifuge 5810 R (Eppendorf, Hamburg, Ger-
many). Serum and EDTA-plasma samples were sent to
Stillwater Medical Center for analyses of serum glucose,
lipids, albumin, liver, renal, and thyroid functions tests,
and hematocrit and hemoglobin assays using standard
laboratory techniques. Plasma and serum samples were
stored at -80°C for subsequent analyses of biomarkers of
oxidative stress and inflammation, and plasma ellagic
acid.
Dietary analyses
Dietary analyses were conducted at baseline and four
weeks of the study. Subjects were asked to maintain a
detailed 3-day food records which were analyzed by a
trained registered dietitian using Food Processor (version
8.3, ESHA Research Inc.). Subjects were also asked to pro-
vide food labels or recipes for accurate analyses of their
intakes.
Biomarkers of oxidative stress and inflammation
Plasma concentrations of ox-LDL were measured in dupli-
cate with ELISA kits (Mercodia, Uppsala, Sweden) accord-
ing to the manufacturer's instructions. Lipid peroxidation
was measured in serum as malondialdehyde (MDA) and
4-hydroxynonenal (HNE), using a colorimetric assay
according to the manufacturer's protocol (LPO-586™,
Oxis Health Products, Inc., Portland, OR). The average
intra-assay CV for ox-LDL and MDA & HNE were 5.2 and
3.56%, respectively. Plasma hs-C-reactive protein (CRP)
was measured using a quantitative sandwich enzyme
immunoassay technique (R&D Systems, Minneapolis,
MN). Plasma adiponectin was measured using a Mercodia
Adiponectin ELISA, a solid phase two-site enzyme immu-
noassay (Mercodia, Uppsala, Sweden). The average intra-
assay CV for hsCRP and adiponectin were 3.5 and 4.8%,
respectively. Plasma ellagic acid was measured using
HPLC-UV procedures as described previously by Seeram
et al. [18]. The minimum detectable level of ellagic acid in
our assay was 3.2 ng/mL. The inter-assay CV was 7.8%.
Statistical analyses
Paired t tests were used for continuous variables, which
had an overall normal distribution. Data were graphed for
outliers. Variables were compared at baseline and at four
weeks of the study using SPSS® 16.0 for Windows (SPSS
Inc., Chicago, IL, USA). Our study was adequately pow-
ered to assess differences in the variables of interests with
a sample size of sixteen. Statistical significance was
accepted at a probability value of < 0.05 (two-sided test).
Results
Sixteen females completed the study. No significant out-
liers were detected. The study subjects were free from
Table 1: Composition of freeze-dried strawberry powder. Values 
per 50 g of the freeze-dried strawberry powder (10% fresh 
weight)
Carbohydrates (g) 33.0
Protein (g) 3.5
Fat (g) 0.5
Calories (kcal) 150.0
Moisture (%) 10.0
Ash (g) 3.17
Vitamin C (mg) 109.0
Total Phenolics (mg)1 2006.0
Total Anthocyanins (mg)2 154.0
Ellagic acid (mg) 41.0
Phytosterols (mg) 50.0
Total dietary fiber (%) 8.0
Source: California Strawberry Commission (Watsonville, CA, USA)
1expresssed as mg gallic acid equivalents
2expressed as mg cyanidin-3-glucoside equivalentsNutrition Journal 2009, 8:43 http://www.nutritionj.com/content/8/1/43
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chronic disease and were not on any prescription medica-
tions on a regular basis. Nine out of sixteen subjects
(56%) were taking a multivitamin/mineral supplement
on a regular basis and continued to do so while in the
study. No differences were found between the supplement
users and non users on the parameters of interest. All sub-
jects maintained their usual diet and exercise patterns dur-
ing the 4-week study.
Serum total and LDL-cholesterol levels were significantly
reduced at 4 weeks versus baseline as shown in Table 2.
No significant differences were noted in case of fasting
glucose, triglycerides, HDL- and VLDL-cholesterol levels.
Body weight, waist circumference, systolic and diastolic
blood pressure were not significantly affected by freeze-
dried strawberry powder supplementation.
A decreasing trend in oxidized-LDL levels was observed.
Oxidized-LDL decreased from 117.98 ± 7.51 U/l at base-
line to 108.96 ± 7.27 U/l at four weeks (p = 0.123). Serum
MDA & HNE showed a significant decrease at 4 weeks
compared to baseline (p < 0.01). No significant differ-
ences were noted in CRP and adiponectin concentrations
(Table 2). Based on our lower limit of detection for the
assay (3.2 ng/mL), plasma ellagic acid was non-detectable
in all subjects at baseline, and 13 out of 16 subjects
showed an increase at 4 weeks. The average plasma level
of ellagic acid at 4 weeks was 8.5 ± 4.3 ng/mL. However,
no significant correlations were found between increased
ellagic acid and other variables of interests.
As illustrated in Table 3, no significant differences were
noted in dietary intakes at four weeks versus baseline.
The study had no drop-outs although two subjects com-
plained of a feeling of tingling and numbness of the
extremities and flatulence during the first few days of the
study. However, these symptoms were temporary and did
not affect the subjects' compliance in the study. The straw-
berry drink was well tolerated and all participants showed
active compliance with the study schedule.
Discussion
With the rising costs of health care and pharmacological
interventions, the role of natural dietary measures in the
prevention and treatment of cardiovascular diseases has
gained special attention. To our knowledge this is the first
study investigating the effects of freeze-dried strawberry
powder supplementation on selected cardiovascular risk
factors in women with metabolic syndrome. Serum cho-
lesterol levels were lowered following four weeks of
freeze-dried strawberry consumption, which suggests a
need for further study to determine if this might be a
potential dietary approach to lowering cholesterol levels
in obese women. In our study, subjects consumed a daily
dose of 50 g freeze-dried strawberry powder which is
equivalent to approximately 500 g fresh strawberries (3.5
cups). Our study findings add to the scientific basis sup-
porting the cardio protective role of fruits and vegetables
in human diet [7,19]. Some of the known cardio protec-
tive agents in strawberries include phytochemicals, vita-
min C, folic acid, potassium, fiber and phytosterols,
Table 2: Effects of FSP supplementation on anthropometrics, blood pressure, clinical variables, oxidative stress, and inflammation 
(Mean values and standard error).
Variables Baseline Post-intervention (4 weeks)
(n 16) (n 16)
Mean SE Mean SE
Body weight (kg) 102.0 5.6 102.6 5.7
BMI 38.6 2.3 38.78 2.3
Waist circumference (inches) 43.0 1.5 44.0 1.5
Systolic blood pressure (mm Hg) 135.0 3.3 134.5 3.5
Diastolic blood pressure (mm Hg) 88.0 2.6 87.5 2.5
Glucose (mmol/L) 5.22 0.2 5.18 0.1
Total cholesterol (mmol/L) 5.32 0.2 5.05 0.16*
Triglycerides (mmol/L) 1.7 0.16 1.8 0.18
LDL-cholesterol (mmol/L) 3.2 0.17 3.0 0.12*
HDL-cholesterol (mmol/L) 1.24 0.05 1.22 0.04
VLDL-cholesterol (mmol/L) 1.0 0.2 0.83 0.08
Oxidized LDL (U/L) 118.0 7.5 109.0 7.3
MDA & HNE (μM) 1.4 0.04 1.2 0.03*
hsCRP (mg/L) 9.5 0.5 9.3 0.5
Adiponectin (μg/mL) 9.7 1.0 11.2 1.3
FSP-freeze-dried strawberry powder; *significantly different from baseline (p < 0.05)Nutrition Journal 2009, 8:43 http://www.nutritionj.com/content/8/1/43
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contributing to the antioxidant, anti-inflammatory, and
hypocholesterolemic effects of strawberries [1,15,20].
To our knowledge, the effects of strawberry consumption
on features of metabolic syndrome, oxidative stress, and
inflammation have not been investigated in obese adults.
Jenkins et al. have previously reported the cardiovascular
health benefits of strawberries [21]. In their study, 28
hyperlipidemic subjects with an average baseline total and
LDL-cholesterol of 5.62 ± 0.14 mmol/L and 3.61 ± 0.13
mmol/L, respectively, did not show any significant differ-
ences in lipid levels following intake of 454 g fresh straw-
berries everyday for four weeks. However, the study
showed a significant reduction in thiobarbituric acid-reac-
tive substances in LDL, indicating reduced oxidative dam-
age to lipids. It should be noted that subjects in their study
were following a cholesterol-lowering diet including soy,
viscous fiber, plant sterols, and nuts for a mean of 2.5
years prior to strawberry supplementation for 4 weeks.
Thus, the antioxidant effects of strawberries could have
been confounded by the various dietary modifications
made by these subjects [22]. In our study, subjects had a
lower baseline total and LDL-cholesterol levels (5.32 ± 0.2
mmol/L and 3.2 ± 0.17 mmol/L, respectively) compared
to the reported data by Jenkins et al. which indicates that
freeze-dried strawberry powder supplementation may
reduce cholesterol in subjects with mild elevation than
those with high cholesterol levels. Cholesterol-lowering
effects of freeze-dried strawberry powder may be attribut-
able to the phytosterol, fiber, or phytochemical content of
strawberries. Phytosterols have been shown to inhibit
cholesterol absorption and lower cholesterol levels in
clinical studies [22,23]. Since plant foods are natural
sources of phytosterols, supplementation of concentrated
fruit powder may be a novel approach to lowering
selected CVD risk factors in women with clinically signif-
icant obesity (BMI >35), as noted in our study. Further-
more, the total dietary fiber content of the strawberry
drink (8 g/day) may also contribute to the cholesterol
lowering effects. The decreasing trend in oxidized-LDL in
our study bears consideration and further research.
Because oxidized-LDL plays a critical role in the initiation
and progression of atherosclerosis [24], long-term supple-
mentation of antioxidant-rich fruits, like strawberries may
be beneficial in slowing or reversing the process of athero-
sclerotic cardiovascular disease in obese women with met-
abolic risk factors.
Our study findings of a significant decrease in MDA &
HNE support similar effects reported by Pajk et al. in a
porcine model of oxidative stress following supplementa-
tion of a fruit mixture including strawberries [25]. Thus,
further study is warranted to examine whether free radical
damage can be significantly decreased by dietary interven-
tion with freeze-dried strawberry powder. Due to the lack
of a control group and the small sample size comprising
only women, our study results cannot be widely general-
ized. But, the high compliance rate, bioavailability of
strawberry ellagic acid, and tolerability of the freeze-dried
strawberry drink, suggests that larger, controlled interven-
tions using strawberry supplementation are feasible. Fur-
thermore, since none of our subjects were on lipid-
lowering medications, and no significant dietary changes
were noted before and after supplementation, our data
Table 3: Dietary nutrient intakes before and after FSP supplementation (Mean values and standard error).
Variables Baseline Post-intervention (4-weeks)
(n 16) (n 16)
Mean SE Mean SE
Energy (kcal) 1738.28 103.3 1790.27 136.4
Protein (g) 67.89 5.68 76.05 6.05
Carbohydrate (g) 206.84 16.55 203.80 17.0
Fiber (g) 14.25 1.34 14.78 1.60
Total fat (g) 69.62 4.7 74.96 7.4
Saturated fat (g) 23.96 1.99 26.48 2.36
Monounsaturated fat (g) 15.92 2.15 18.99 2.84
Polyunsaturated fat (g) 7.12 1.01 9.17 2.0
Cholesterol (mg) 221.04 35.0 261.24 30.68
Carotenoids (RE) 258.35 75.2 291.15 54.0
Vitamin C (mg) 68.72 22.1 69.57 14.0
Vitamin E (mg) 3.68 0.73 4.58 1.13
Copper (mg) 0.63 0.1 0.76 0.1
Iron (mg) 12.14 1.25 13.23 1.2
Zinc (mg) 7.06 1.11 9.88 1.43
FSP-freeze-dried strawberry powderNutrition Journal 2009, 8:43 http://www.nutritionj.com/content/8/1/43
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indicate that the improvements in lipids and lipid perox-
idation may possibly be due to strawberry powder supple-
mentation per se. Sub-analyses of the dietary data, among
daily users of dietary supplements, did not show any sig-
nificant differences at 4 weeks on variables of interests,
suggesting that diet and supplementation did not con-
found our study findings. However, such effects need to
be confirmed in well-controlled clinical trials.
Data from the National Health and Nutrition Examina-
tion Survey (2001-2002), reveal that US adults consume
53.5% whole fruit recommendations, mainly as apples,
pears and bananas, while vegetable intake is significantly
below the recommendations by the Dietary Guidelines
for Americans, 2005. Fruit servings include grain-based
desserts and fruit juices which are popular food items, but
constitute a high-fat and high-sugar means of consuming
fruits [26]. Thus, to increase the intake of antioxidant-rich
fruits and vegetables in the diet, concentrated fruit pow-
ders blended as smoothies may be a more attractive and
convenient approach, especially for adults who do not
consume the recommended amounts of fruits and vegeta-
bles. Our data suggest the need for a randomized control-
led trial including a well-defined population of adequate
sample size in assessing the effects of freeze-dried berry
powder, as antioxidants and anti-inflammatory agents in
adults with obesity and related metabolic disorders.
Conclusion
Freeze-dried strawberry powder (FSP), a concentrated
source of strawberry polyphenolic flavonoids, fiber, and
phytosterols is a novel dietary fruit supplement marketed
by selected fruit growers and special promotion groups.
Not enough scientific data is available on the health ben-
efits of this product. Our study shows the potential role of
FSP in lowering total and LDL-cholesterol, and lipid per-
oxidation in women with metabolic syndrome, and sug-
gests the need for larger controlled trials.
Competing interests
This study was supported by a grant from the College of
Human Environmental Sciences at Oklahoma State Uni-
versity. Freeze-dried strawberry powder was kindly
donated by the California Strawberry Commission. This
study is part of our ongoing research on novel functional
foods and CVD risk factors in humans.
Authors' contributions
AB and NB conceived the idea for the study and imple-
mented the study design. MW, KP, & BS administered the
strawberry intervention, subject recruitment and follow-
ups. BS also did blood draws at all visits. NB provided val-
uable statistical assistance. TL provided expertise on lan-
guage and content. AB prepared the manuscript and all
authors have read and approved the final manuscript.
References
1. Hannum SM: Potential impact of strawberries on human
health: a review of the science.  Crit Rev Food Sci Nutr 2004,
44:1-17.
2. Wolfe KL, Kang X, He X, Dong M, Zhang Q, Liu RH: Cellular anti-
oxidant activity of common fruits.  J Agric Food Chem 2008,
56:8418-8426.
3. Wang SY, Jiao H: Scavenging capacity of berry crops on super-
oxide radicals, hydrogen peroxide, hydroxyl radicals, and sin-
glet oxygen.  J Agric Food Chem 2000, 48:5677-5684.
4. Chang WC, Yu YM, Chiang SY, Tseng CY: Ellagic acid suppresses
oxidised low-density lipoprotein-induced aortic smooth
muscle cell proliferation: studies on the activation of extra-
cellular signal-regulated kinase 1/2 and proliferating cell
nuclear antigen expression.  Br J Nutr 2008, 99:709-714.
5. Yu YM, Chang WC, Wu CH, Chiang SY: Reduction of oxidative
stress and apoptosis in hyperlipidemic rabbits by ellagic acid.
J Nutr Biochem 2005, 16:675-681.
6. da Silva Pinto M, Kwon YI, Apostolidis E, Lajolo FM, Genovese MI,
Shetty K: Functionality of bioactive compounds in Brazilian
strawberry (Fragaria × ananassa Duch.) cultivars: evaluation
of hyperglycemia and hypertension potential using in vitro
models.  J Agric Food Chem 2008, 56:4386-4392.
7. Prior RL, Wu X, Gu L, Hager TJ, Hager A, Howard LR: Whole ber-
ries versus berry anthocyanins: interactions with dietary fat
levels in the C57BL/6J mouse model of obesity.  J Agric Food
Chem 2008, 56:647-653.
8. Tsuda T, Ueno Y, Aoki H, Koda T, Horio F, Takahashi N, Kawada T,
Osawa T: Anthocyanin enhances adipocytokine secretion and
adipocyte-specific gene expression in isolated rat adipocytes.
Biochem Biophys Res Commun 2004, 316:149-157.
9. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA,
Jacobs DR Jr: Flavonoid intake and cardiovascular disease
mortality: a prospective study in postmenopausal women.
Am J Clin Nutr 2007, 85:895-909.
10. Sesso HD, Gaziano JM, Jenkins DJ, Buring JE: Strawberry intake,
lipids, C-reactive protein, and the risk of cardiovascular dis-
ease in women.  J Am Coll Nutr 2007, 26:303-310.
11. Park SH, Kim BI, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI,
Kim H, Keum DK, et al.: Body fat distribution and insulin resist-
ance: beyond obesity in nonalcoholic fatty liver disease
among overweight men.  J Am Coll Nutr 2007, 26:321-326.
12. Grattagliano I, Palmieri VO, Portincasa P, Moschetta A, Palasciano G:
Oxidative stress-induced risk factors associated with the
metabolic syndrome: a unifying hypothesis.  J Nutr Biochem
2008, 19:491-504.
13. Chen K, Lindsey JB, Khera A, De Lemos JA, Ayers CR, Goyal A, Vega
GL, Murphy SA, Grundy SM, McGuire DK: Independent associa-
tions between metabolic syndrome, diabetes mellitus and
atherosclerosis: observations from the Dallas Heart Study.
Diab Vasc Dis Res 2008, 5:96-101.
14. Ishizaka N, Ishizaka Y, Yamakado M, Toda E, Koike K, Nagai R: Asso-
ciation between metabolic syndrome and carotid athero-
sclerosis in individuals without diabetes based on the oral
glucose tolerance test.  Atherosclerosis 2009, 204:619-23.
15. Carkeet C, Clevidence BA, Novotny JA: Anthocyanin excretion
by humans increases linearly with increasing strawberry
dose.  J Nutr 2008, 138:897-902.
16. Mullen W, Edwards CA, Serafini M, Crozier A: Bioavailability of
pelargonidin-3-O-glucoside and its metabolites in humans
following the ingestion of strawberries with and without
cream.  J Agric Food Chem 2008, 56:713-719.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin
BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa
F: American Heart Association; National Heart, Lung, and
Blood Institute. Diagnosis and management of the metabolic
syndrome: an American Heart Association/National Heart,
Lung, and Blood Institute Scientific Statement.  Circulation
2005, 112:2735-2752.
18. Seeram NP, Lee R, Heber D: Bioavailability of ellagic acid in
human plasma after consumption of ellagitannins from
pomegranate (Punica granatum L.) juice.  Clin Chim Acta 2004,
348:63-68.
19. Iqbal R, Anand S, Ounpuu S, Islam S, Zhang X, Rangarajan S, Chifamba
J, Al-Hinai A, Keltai M, Yusuf S, INTERHEART Study Investigators:
Dietary patterns and the risk of acute myocardial infarctionPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Nutrition Journal 2009, 8:43 http://www.nutritionj.com/content/8/1/43
Page 7 of 7
(page number not for citation purposes)
in 52 countries: results of the INTERHEART study.  Circulation
2008, 118:1929-1937.
20. California Strawberry Commission: Health & Nutrition  2009
[http://www.calstrawberry.com/health/default.asp]. (accessed May
2009)
21. Jenkins DJ, Nguyen TH, Kendall CW, Faulkner DA, Bashyam B, Kim
IJ, Ireland C, Patel D, Vidgen E, Josse AR, et al.: The effect of straw-
berries in a cholesterol-lowering dietary portfolio.  Metabolism
2008, 57:1636-1644.
22. Rudkowska I, AbuMweis SS, Nicolle C, Jones PJ: Cholesterol-low-
ering efficacy of plant sterols in low-fat yogurt consumed as
a snack or with a meal.  J Am Coll Nutr 2008, 27:588-595.
23. Noakes M, Clifton PM, Doornbos AM, Trautwein EA: Plant sterol
ester-enriched milk and yoghurt effectively reduce serum
cholesterol in modestly hypercholesterolemic subjects.  Eur J
Nutr 2005, 44:214-222.
24. Nickel T, Schmauss D, Hanssen H, Sicic Z, Krebs B, Jankl S, Summo
C, Fraunberger P, Walli AK, Pfeiler S, et al.: oxLDL uptake by den-
dritic cells induces upregulation of scavenger-receptors,
maturation and differentiation.  Atherosclerosis 2009 in press.
25. Pajk T, Rezar V, Levart A, Salobir J: Efficiency of apples, strawber-
ries, and tomatoes for reduction of oxidative stress in pigs as
a model for humans.  Nutrition 2006, 22:376-384.
26. Bachman JL, Reedy J, Subar AF, Krebs-Smith SM: Sources of food
group intakes among the US population, 2001-2002.  J Am Diet
Assoc 2008, 108:804-814.